CytoSorbents Corporation (CTSO)

[andy55q]

New on ClinicalTrials.gov
The Effect of Early Cytokine Absorption on the SIRS and Organ Dysfunction in the First 48 Hours of Septic Shock
This study is ongoing, but not recruiting participants.
Sponsor:
Domonkos Trásy
Information provided by (Responsible Party):
Domonkos Trásy, Szeged University
ClinicalTrials.gov Identifier:
NCT02288975
First received: November 5, 2014
Last updated: November 12, 2014
Last verified: November 2014
The aim of the study is to investigate the effect of CytoSorb® treatment within the first 48 hours of septic shock on organ dysfunction, microcirculation and on the cytokine storm as monitored by leukocyte activation and inflammatory mediators.
http://clinicaltrials.gov/ct2/show?term=CytoSorb&rank=4